The Future of Regenerative Therapy

We are proud to offer products to help your healing journey and make your recovery faster, less painful, and more effective.

Tissue Allograft characteristics as described in scientific literature:

  • Regulation of Inflammation

    Tissue allografts are thought to regulate inflammation in the body and to help reconstruct new, healthy tissue.

  • Stem Cell Recruitment®

    Growth factors are naturally occurring in tissue allografts. Growth factors are responsible for the recruitment of the body’s healing components to promote the tissue repair and reconstruction process.

  • Non-Steroidal

    Tissue allografts are naturally occurring; they do not contain steroids or other pharmaceuticals. Because of the nature of the human tissue the potential for long-term negative health implications is limited.

  • Non-Immunogenic

    Tissue allografts are thought to express immune-privileged antigens, which may reduce the risk of graft intolerance. We believe there is very little risk of foreign body reaction.

  • Are Tissue Allografts covered by insurance?

    Yes, tissue allografts may be covered by insurances. Consult your physician to see if you are covered.

*Stem Cell Recruitment Therapy® Disclaimer: Stem Cell Recruitment® (SCR), Stem Cell Recruitment Therapy® (SCRT), Stem Cell Recruitment Facial®, and Vivaderm™ are trademarks of Russell Health, Inc. The treatments described on this marketing are not considered to be standard of care for any condition or disease. SCR, SCRT, SCR Facial and Vivaderm™ products attempt to utilize acellular, minimally manipulated tissue allografts and are comprised of tissue allograft components intended for homologous use to supplement tissue. Tissue allografts are are classified by the Food and Drug Administration (FDA) as Human Cell, Tissue and Cellular and Tissue-Based Products (HCT/P) that are regulated solely under section 361 of the Public Health Service (PHS) Act. FDA recognizes that human tissue was designed, or evolved, to perform certain functions in the human body with exquisite safety and effectiveness. As an HCT/P regulated solely under the Section 361 of the PHS Act, tissue allografts are exempt from FDA pre-market review, clearance, and approval from FDA. Please consult your doctor to see if a tissue allograft is right for you. No medical advice has been offered herein. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Results may vary. This human tissue should not be used for the treatment of COVID-19.

180 Health Services